PAVmed Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from PAVmed Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $597 per $100 of sales comes from others' credit, against $644 from others' credit three years earlier. Less money tied up than almost all Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 72% of its market value (net debt). Lower than 94% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-276.8×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 92% of Healthcare companies in United States.
Cash Locked Ratio
−$597Money owed to suppliers is larger than money owed by customers plus stock: $597 per $100 of sales comes from others' credit, against $644 from others' credit three years earlier.
Less money tied up than almost all Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 81%
Sales fell 81% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-81% / -28%In 3 years sales changed by -81% while total assets changed by -28%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-0.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 68% of Healthcare companies in United States.
Cash Cushion Ratio
−72%Debt, after subtracting cash, equals 72% of its market value (net debt).
Lower than 94% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
PAVmed Inc. made a loss over the last year. PAVmed Inc. owes $0.52 for every $1 it owns. Net profit fell 99% in the year to Dec 2025.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPAVmed Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.47The share price is 0.47 times PAVmed Inc.'s book value per share, lower than 92% of Healthcare companies in United States.
Market cap
$16 MThe total market value of all of PAVmed Inc.'s shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$35 MWhat PAVmed Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$4.38Net worth divided by the number of shares. The share price of $2.05 is 0.5 times this, which is the P/B above.
Return on equity (ROE)
-64.8%PAVmed Inc. lost 64.8% of its shareholders' money over the last year, lower than 59% of Healthcare companies in United States.
Owes vs Owns
0.52×PAVmed Inc. owes $0.52 for every $1 it owns (moderate), higher than 58% of Healthcare companies in United States.
Dividend yield
NonePAVmed Inc. does not currently pay a dividend.
Revenue growth
-98%Revenue fell 98% in the year to Dec 2025, and shrank 43% a year on average over 3 years.
Profit growth
-99%Net profit fell 99% in the year to Dec 2025.
Profit margin
564.8%PAVmed Inc. keeps $565 of every $100 of revenue as net profit.
Cash quality
-13.0×Cash from PAVmed Inc.'s business was -13.0× its reported profit in the year to Dec 2025 — the business used cash even though it reported a profit.
Interest cover
Not coveredPAVmed Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtPAVmed Inc. had $12 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For PAVmed Inc.: $16 M ÷ $35 M (30 Jun 2026) = 0.5.
What is PAVmed Inc.'s return on equity?
PAVmed Inc. lost 64.8% of its shareholders' money over the last year, lower than 59% of Healthcare companies in United States.
How much does PAVmed Inc. owe compared with what it owns?
PAVmed Inc. owes $0.52 for every $1 it owns (moderate), higher than 58% of Healthcare companies in United States.
Does PAVmed Inc. pay a dividend?
No. PAVmed Inc. does not currently pay a dividend.
Is PAVmed Inc.'s revenue growing?
Revenue fell 98% in the year to Dec 2025, and shrank 43% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.